News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

HK data: LAI antipsychotics superior to oral antipsychotics in older patients with schizophrenia
28 Oct 2025
byKanas Chan
Long-acting injectable (LAI) antipsychotics are associated with lower risks of disease relapse and mortality than oral antipsychotics in older patients with schizophrenia, a population-based study in Hong Kong has shown.
28 Oct 2025

Enzalutamide-ADT a win for biochemically recurrent prostate cancer
27 Oct 2025
byAudrey Abella
In the final overall survival (OS) analysis of the phase III EMBARK trial, the combination of enzalutamide and androgen deprivation therapy (ADT; leuprolide acetate) delivers a significant OS benefit in men with high-risk biochemically recurrent (hrBCR) prostate cancer without evidence of metastases on conventional imaging.
27 Oct 2025







